Market Research Report

Global Animal Vaccines Market Report By Product (Attenuated Vaccines, Inactivated Vaccines, Subunit Vaccines, Toxoid Vaccines, Conjugate Vaccines, Recombinant Vaccines, DNA Vaccines), By Animal Type (Companion animal (Dogs, Cats), Livestock animal (Cattle, Pigs, Poultry, Sheep, Others), Aquaculture) And By Regions - Industry Trends, Size, Share, Growth, Estimation and Forecast, 2021-2028

ID:VMR11218009
April 2022
Report Formats: Report Formats
The global demand for Animal Vaccines Market is presumed to reach the market size of nearly USD XX MN by 2028 from USD XX MN in 2021 with a CAGR of XX% under the study period 2022 - 2028.

Animal vaccines prevent diseases from spreading, protecting both animal and human health, which is critical given the public's reliance on animals. Food, meat, milk, protein, and other commercial items such as leather and wool are all derived from animals. Rabies vaccinations, foot, and mouth disease vaccines, and equine influenza virus vaccines are among the most regularly used veterinary vaccines, which inhibit the transfer of infectious pathogens by simulating naturally acquired immunity. 

Market Dynamics

With new animal diseases, it is critical to continue developing vaccinations. The market for animal vaccinations is restrained by a lack of animal health awareness and the likelihood of adverse effects of veterinary vaccines on human and other animal health. The rise in pet ownership has spurred the market's expansion. Because of the rise in pet ownership in affluent nations and the expansion in cattle and poultry in emerging countries, the animal vaccines market is predicted to grow steadily. Furthermore, a spike in investment in vaccine R&D that inhibits the growth of antibiotic-resistant pathogens is boosting the demand for animal vaccines. Moreover, advances in vaccination products and the manufacture of animal vaccines for hybrid animals are helping to expand the animal vaccines industry.

The research report covers Porter’s Five Forces Model, Market Attractiveness Analysis, and Value Chain analysis. These tools help to get a clear picture of the industry’s structure and evaluate the competition attractiveness at a global level. Additionally, these tools also give an inclusive assessment of each segment in the global market of animal vaccines. The growth and trends of animal vaccines industry provide a holistic approach to this study. 

Market Segmentation

This section of the animal vaccines market report provides detailed data on the segments at country and regional level, thereby assisting the strategist in identifying the target demographics for the respective product or services with the upcoming opportunities. 

By Product
  • Attenuated Vaccines
  • Inactivated Vaccines
  • Subunit Vaccines
  • Toxoid Vaccines
  • Conjugate Vaccines
  • Recombinant Vaccines
  • DNA Vaccines

By Animal Type
  • Companion Animal (Dogs, Cats)
  • Livestock Animal (Cattle, Pigs, Poultry, Sheep, Others)
  • Aquaculture

Regional Analysis

This section covers the regional outlook, which accentuates current and future demand for the Animal Vaccines market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the report focuses on demand, estimation, and forecast for individual application segments across all the prominent regions.

Global Animal Vaccines Market Share by Region (Representative Graph)
Global Animal Vaccines Market Share


The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the animal vaccines market include Merck & Co., Inc., Zoetis Inc., Ceva Santé Animale, Sanofi S.A., Romvac, Vaxxinova, Biovac, Merial, Boehringer Ingelheim GmbH and Anicon Labor GmbH. The other players that operate in animal vaccines market include Nexvet, PHL Associates, Inc., Hygieia Biological Laboratories, Colorado Serum Company, Pfizer, and Arko Laboratories, Ltd. This section consists of a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.

METHODOLOGY:

This market research report has been produced by gathering information based on primary and secondary research. Secondary research has been done using various sources, including (but not limited to) Company Websites, Paid Data Sources, Technical Journals, Financial Reports, SEC Filings, and other different industry publications. Additionally, our team conducts extensive primary research with key industry participants to gather first-hand data. The data is then analyzed and validated by industry experts.

In case you have any custom requirements, do write to us. Our research team can offer a customized report as per your need.

Frequently Asked Questions (FAQs) about this Report

1 . PREFACE
       1.1. Report Description
           1.1.1. Objective
           1.1.2. Target Audience
           1.1.3. Unique Selling Proposition (USP) & offerings
       1.2. Research Scope
       1.3. Research Methodology
           1.3.1. Market Research Process
           1.3.2. Market Research Methodology
 
2 . EXECUTIVE SUMMARY
       2.1. Highlights of Market
       2.2. Global Market Snapshot
 
3 . ANIMAL VACCINES – INDUSTRY ANALYSIS
       3.1. Introduction - Market Dynamics
       3.2. Market Drivers
       3.3. Market Restraints
       3.4. Opportunities
       3.5. Industry Trends
       3.6. Porter’s Five Force Analysis
       3.7. Market Attractiveness Analysis
           3.7.1 Market Attractiveness Analysis By Product
           3.7.2 Market Attractiveness Analysis By Animal Type
           3.7.3 Market Attractiveness Analysis By Region
 
4 . VALUE CHAIN ANALYSIS
       4.1. Value Chain Analysis
       4.2. Raw Material Analysis
           4.2.1. List of Raw Materials
           4.2.2. Raw Material Manufactures List
           4.2.3. Price Trend of Key Raw Materials
       4.3. List of Potential Buyers
       4.4. Marketing Channel
           4.4.1. Direct Marketing
           4.4.2. Indirect Marketing
           4.4.3. Marketing Channel Development Trend
 
5 . IMPACT ANALYSIS OF COVID-19 OUTBREAK
       5.1. Impact Analysis of Covid-19 Outbreak
           5.1.1. Direct Impact on Production
           5.1.2. Supply Chain and Market Disruption
           5.1.3. Financial Impact on Firms and Financial Markets
       5.2. COVID-19 Impact Analysis by Production, Import, Export and Demand
       5.3. Market: Pre V/S Post COVID-19
       5.4. Estimated Impact of the Coronavirus (COVID-19) Epidemic 
       5.5. COVID-19: Micro and Macro Factor Analysis
 
6 . GLOBAL ANIMAL VACCINES MARKET ANALYSIS BY PRODUCT
       6.1 Overview by Product
       6.2 Historical and Forecast Data
       6.3 Analysis by Product
       6.4 Attenuated Vaccines Historic and Forecast Sales by Regions
       6.5 Inactivated Vaccines Historic and Forecast Sales by Regions
       6.6 Subunit Vaccines Historic and Forecast Sales by Regions
       6.7 Toxoid Vaccines Historic and Forecast Sales by Regions
       6.8 Conjugate Vaccines Historic and Forecast Sales by Regions
       6.9 Recombinant Vaccines Historic and Forecast Sales by Regions
       6.10. DNA Vaccines Historic and Forecast Sales by Regions
 
7 . GLOBAL ANIMAL VACCINES MARKET ANALYSIS BY ANIMAL TYPE
       7.1 Overview by Animal Type
       7.2 Historical and Forecast Data
       7.3 Analysis by Animal Type
       7.4 Companion Animal (Dogs, Cats) Historic and Forecast Sales by Regions
       7.5 Livestock Animal (Cattle, Pigs, Poultry, Sheep, Others) Historic and Forecast Sales by Regions
       7.6 Aquaculture Historic and Forecast Sales by Regions
 
8 . GLOBAL ANIMAL VACCINES MARKET ANALYSIS BY GEOGRAPHY
       8.1. Regional Outlook
       8.2. Introduction
       8.3. North America Sales Analysis
           8.3.1. Overview, Historic and Forecast Sales Analysis
           8.3.2. North America By Segment Sales Analysis
           8.3.3. North America By Country Sales Analysis
           8.3.4. United State Sales Analysis
           8.3.5. Canada Sales Analysis
           8.3.6. Mexico Sales Analysis
       8.4. Europe Sales Analysis
           8.4.1. Overview, Historic and Forecast Sales Analysis
           8.4.2. Europe by Segment Sales Analysis
           8.4.3. Europe by Country Sales Analysis
           8.4.4. United Kingdom Sales Analysis
           8.4.5. France Sales Analysis
           8.4.6. Germany Sales Analysis
           8.4.7. Italy Sales Analysis
           8.4.8. Russia Sales Analysis
           8.4.9. Rest Of Europe Sales Analysis
       8.5. Asia Pacific Sales Analysis
           8.5.1. Overview, Historic and Forecast Sales Analysis
           8.5.2. Asia Pacific by Segment Sales Analysis
           8.5.3. Asia Pacific by Country Sales Analysis
           8.5.4. China Sales Analysis
           8.5.5. India Sales Analysis
           8.5.6. Japan Sales Analysis
           8.5.7. South Korea Sales Analysis
           8.5.8. Australia Sales Analysis
           8.5.9. Rest Of Asia Pacific Sales Analysis
       8.6. Latin America Sales Analysis
           8.6.1. Overview, Historic and Forecast Sales Analysis
           8.6.2. Latin America by Segment Sales Analysis
           8.6.3. Latin America by Country Sales Analysis
           8.6.4. Brazil Sales Analysis
           8.6.5. Argentina Sales Analysis
           8.6.6. Peru Sales Analysis
           8.6.7. Chile Sales Analysis
           8.6.8. Rest of Latin America Sales Analysis
       8.7. Middle East & Africa Sales Analysis
           8.7.1. Overview, Historic and Forecast Sales Analysis
           8.7.2. Middle East & Africa by Segment Sales Analysis
           8.7.3. Middle East & Africa by Country Sales Analysis
           8.7.4. Saudi Arabia Sales Analysis
           8.7.5. UAE Sales Analysis
           8.7.6. Israel Sales Analysis
           8.7.7. South Africa Sales Analysis
           8.7.8. Rest Of Middle East And Africa Sales Analysis
 
9 . COMPETITIVE LANDSCAPE OF THE ANIMAL VACCINES COMPANIES
       9.1. Animal Vaccines Market Competition
       9.2. Partnership/Collaboration/Agreement
       9.3. Merger And Acquisitions
       9.4. New Product Launch
       9.5. Other Developments
 
10 . COMPANY PROFILES OF ANIMAL VACCINES INDUSTRY
       10.1. Top Companies Market Share Analysis
       10.2. Market Concentration Rate
       10.3. Merck & Co. Inc.
           10.3.1. Company Overview
           10.3.2. Company Revenue
           10.3.3. Products
           10.3.4. Recent Developments
       10.4. Zoetis Inc.
           10.4.1. Company Overview
           10.4.2. Company Revenue
           10.4.3. Products
           10.4.4. Recent Developments
       10.5. Ceva Santé Animale
           10.5.1. Company Overview
           10.5.2. Company Revenue
           10.5.3. Products
           10.5.4. Recent Developments
       10.6. Sanofi S.A.
           10.6.1. Company Overview
           10.6.2. Company Revenue
           10.6.3. Products
           10.6.4. Recent Developments
       10.7. Romvac
           10.7.1. Company Overview
           10.7.2. Company Revenue
           10.7.3. Products
           10.7.4. Recent Developments
       10.8. Vaxxinova
           10.8.1. Company Overview
           10.8.2. Company Revenue
           10.8.3. Products
           10.8.4. Recent Developments
       10.9. Biovac
           10.9.1. Company Overview
           10.9.2. Company Revenue
           10.9.3. Products
           10.9.4. Recent Developments
       10.10. Merial
           10.10.1. Company Overview
           10.10.2. Company Revenue
           10.10.3. Products
           10.10.4. Recent Developments
       10.11. Boehringer Ingelheim GmbH
           10.11.1. Company Overview
           10.11.2. Company Revenue
           10.11.3. Products
           10.11.4. Recent Developments
       10.12. Anicon Labor GmbH.
           10.12.1. Company Overview
           10.12.2. Company Revenue
           10.12.3. Products
           10.12.4. Recent Developments
       10.13. Nexvet
           10.13.1. Company Overview
           10.13.2. Company Revenue
           10.13.3. Products
           10.13.4. Recent Developments
       10.14. PHL Associates Inc.
           10.14.1. Company Overview
           10.14.2. Company Revenue
           10.14.3. Products
           10.14.4. Recent Developments
       10.15. Hygieia Biological Laboratories
           10.15.1. Company Overview
           10.15.2. Company Revenue
           10.15.3. Products
           10.15.4. Recent Developments
       10.16. Colorado Serum Company
           10.16.1. Company Overview
           10.16.2. Company Revenue
           10.16.3. Products
           10.16.4. Recent Developments
       10.17. Pfizer
           10.17.1. Company Overview
           10.17.2. Company Revenue
           10.17.3. Products
           10.17.4. Recent Developments
       10.18. Arko Laboratories Ltd.
           10.18.1. Company Overview
           10.18.2. Company Revenue
           10.18.3. Products
           10.18.4. Recent Developments
 
 *Note - in company profiling, financial details and recent development are subject to availability or might not be covered in case of private companies
 
 LIST OF TABLES
 

  •  Market Snapshot
  •  Drivers : Impact Analysis
  •  Restraints : Impact Analysis
  •  List of Raw Material
  •  List of Raw Material Manufactures
  •  List of Potential Buyers
  •  COVID-19 Impact Analysis by Production, Import, Export and Demand
  •  Pre V/S Post COVID-19
  •  Estimated Impact Of The Coronavirus (Covid-19) Epidemic
  •  COVID-19: Micro and Macro Factor Analysis
  •  Analysis by Product (USD MN)
  •  Attenuated Vaccines Market Sales by Geography (USD MN)
  •  Inactivated Vaccines Market Sales by Geography (USD MN)
  •  Subunit Vaccines Market Sales by Geography (USD MN)
  •  Toxoid Vaccines Market Sales by Geography (USD MN)
  •  Conjugate Vaccines Market Sales by Geography (USD MN)
  •  Recombinant Vaccines Market Sales by Geography (USD MN)
  •  DNA Vaccines Market Sales by Geography (USD MN)
  •  Analysis Market by Animal Type (USD MN)
  •  Companion Animal (Dogs, Cats) Market Sales by Geography (USD MN)
  •  Livestock Animal (Cattle, Pigs, Poultry, Sheep, Others) Market Sales by Geography (USD MN)
  •  Aquaculture Market Sales by Geography (USD MN)
  •  Global Animal Vaccines Market Sales by Geography (USD MN)
  •  North America Market Analysis (USD MN)
  •  United State Market Analysis (USD MN)
  •  Canada Market Analysis (USD MN)
  •  Mexico Market Analysis (USD MN)
  •  Europe Market Analysis (USD MN)
  •  Europe Market Estimate by Country (USD MN)
  •  United Kingdom Market Analysis (USD MN)
  •  France Market Analysis (USD MN)
  •  Germany Market Analysis (USD MN)
  •  Italy Market Analysis (USD MN)
  •  Russia Market Analysis (USD MN)
  •  Spain Market Analysis (USD MN)
  •  Rest of Europe Market Analysis (USD MN)
  •  Asia Pacific Market Analysis (USD MN)
  •  China Market Analysis (USD MN)
  •  Japan Market Analysis (USD MN)
  •  India Market Analysis (USD MN)
  •  South Korea Market Analysis (USD MN)
  •  Australia Market Analysis (USD MN)
  •  Rest of Asia Pacific Market Analysis (USD MN)
  •  Latin America Market Analysis (USD MN)
  •  Brazil Market Analysis (USD MN)
  •  Argentina Market Analysis (USD MN)
  •  Peru Market Analysis (USD MN)
  •  Chile Market Analysis (USD MN)
  •  Rest of Latin America Market Analysis (USD MN)
  •  Middle East & Africa Market Analysis (USD MN)
  •  Saudi Arabia Market Analysis (USD MN)
  •  UAE Market Analysis (USD MN)
  •  Israel Market Analysis (USD MN)
  •  South Africa Market Analysis (USD MN)
  •  Rest of Middle East and Africa Market Analysis (USD MN)
  •  Partnership/Collaboration/Agreement
  •  Mergers And Acquisition
 
 LIST OF FIGURES
 
  •  Research Scope of Animal Vaccines Report
  •  Market Research Process
  •  Market Research Methodology
  •  Global Animal Vaccines Market Size, by Region (USD MN)
  •  Porters Five Forces Analysis
  •  Market Attractiveness Analysis by Product
  •  Market Attractiveness Analysis by Animal Type
  •  Market Attractiveness Analysis by Region
  •  Value Chain Analysis
  •  Global Market Analysis by Product (USD MN)
  •  Attenuated Vaccines Market Sales by Geography (USD MN)
  •  Inactivated Vaccines Market Sales by Geography (USD MN)
  •  Subunit Vaccines Market Sales by Geography (USD MN)
  •  Toxoid Vaccines Market Sales by Geography (USD MN)
  •  Conjugate Vaccines Market Sales by Geography (USD MN)
  •  Recombinant Vaccines Market Sales by Geography (USD MN)
  •  DNA Vaccines Market Sales by Geography (USD MN)
  •  Global Market Analysis by Animal Type (USD MN)
  •  Companion Animal (Dogs, Cats) Market Sales by Geography (USD MN)
  •  Livestock Animal (Cattle, Pigs, Poultry, Sheep, Others) Market Sales by Geography (USD MN)
  •  Aquaculture Market Sales by Geography (USD MN)
  •  Global Market by Revenue
  •  North America Market by Revenue
  •  Europe Market by Revenue
  •  Asia Pacific Market by Revenue
  •  Latin America Market by Revenue
  •  Middle East & Africa Market by Revenue
  •  Recent Development in Industry
  •  Top Companies Market Share Analysis
 
 * Kindly note that the above listed are the basic tables and figures of the report and are not limited to the TOC.

Buy Chapters or Sections

Avail customized purchase options to meet your exact research needs:

  • Buy sections of this report
  • Buy country level reports
  • Request for historical data
  • Request discounts available for Start-Ups & Universities

Objectives of Study

  • Define and measure the global market
  • Volume or revenue forecast of the global market and its various sub-segments with respect to main geographies
  • Analyze and identify major market trends along with the factors driving or inhibiting the market growth
  • Study the company profiles of the major market players with their market share
  • Analyze competitive developments

Why Choose Us

Client First Policy
Excellent Quality
Robust After Sales Support
24/7 Email Support

Clients

Testimonials